Aramark (ARMK)
NYSEConsumer DiscretionarySpecialty Business ServicesSnapshot 2026-11-04
$50.30-3.88%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionarySpecialty Business ServicesSnapshot 2026-11-04
Research Workspace
Put ARMK beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Discretionary is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Recent financial performance freshly dropped to the bottom half of its industry.
View ThesisRanks in the weakest quality tier of its industry — roughly the bottom 42%, softest on share dilution.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskARMK's recent financial performance has fallen to the bottom half of its industry. This drop breaks the core reason to own the stock. Revenue growth slowed to 9% in the latest quarter. The company still beat earnings expectations by 8.3%. The stock trades at 25 times earnings. The peer median is 15.6 times earnings. This premium to peers is a key risk. The market has not fully reacted to the performance drop. Peer multiples imply a price about 17% below where it trades. The thesis has broken. This read is provisional.
Trailing returns as of 2026-11-05. ARMK is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 16 analysts currently covering ARMK (as of Nov 2026).
Based on 9 Wall Street analysts offering 12-month price targets for ARMK in the last 4 months.
Continue this research
Compare ARMK with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| ARMK Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-11-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Discretionary (broad) — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put ARMK next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand Aramark Nexus platform in hyperscale AI data centers
New contract supports growth in AI data center expansion.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-11-05. EPS is implied from price ÷ P/E. Not investment advice.
Current $50.30
The last 12 months of price, then the range of analyst 12-month targets from today’s $50.30.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Drive strong organic revenue growth
Core growth and Nexus expansion align with growth objectives.
Advances: Expand Aramark Nexus platform in hyperscale AI data centers
Nexus expansion aligns with growth objectives and shows strong momentum.
Advances: Drive strong organic revenue growth
Revenue growth acceleration supports strong organic growth objective.
Advances: Expand Aramark Nexus platform in hyperscale AI data centers
Analyst upgrade reflects confidence in data center growth.
Downgrade suggests potential revenue growth issues.
Advances: Increase revenue growth
Targets significant revenue growth aligned with management's objectives.
Advances: Increase revenue growth
Strong revenue growth confirms management's growth objective.
